Propranolol Use During Pregnancy
Propranolol can be used during pregnancy but should be avoided in the first trimester if possible, and requires careful monitoring due to potential risks of fetal growth restriction and neonatal complications. 1, 2
Safety Profile and Recommendations
Propranolol is classified as a pregnancy Category C medication by the FDA, indicating that:
- It is generally considered safe for use during pregnancy but with some important caveats 1
- It has a Class IIa recommendation (should be considered) for management of supraventricular tachycardia during pregnancy 1
- It should be avoided during the first trimester whenever possible 1
Potential Risks to Consider
Maternal Considerations
- Propranolol's pharmacodynamic effects may be enhanced during pregnancy, requiring potential dose adjustments 3
- Monitoring is needed as pregnancy can alter drug effects even without pharmacokinetic changes 3
Fetal and Neonatal Risks
Intrauterine Growth Restriction:
Neonatal complications that may occur but are not invariable:
Clinical Decision Algorithm
First-line approach for pregnant women requiring beta-blockade:
If propranolol is necessary:
For acute conversion of SVT during pregnancy:
For long-term management during pregnancy:
Important Monitoring Considerations
- Regular fetal growth monitoring throughout pregnancy
- Blood glucose monitoring in the neonate after delivery
- Cardiac monitoring for bradycardia in the neonate
- Respiratory monitoring in the immediate postpartum period
Key Practice Points
- Beta-blockers with selective β1 properties (like metoprolol) are theoretically preferable to propranolol during pregnancy 1
- Prospective randomized studies have failed to demonstrate a higher incidence of complications with beta-blockers compared to placebo, but caution is still warranted 1
- Propranolol is excreted in human milk, so caution should be exercised during breastfeeding 2
- The benefits of propranolol treatment must clearly outweigh the potential risks to justify its use during pregnancy 2